These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10687970)

  • 1. Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis.
    Nam RK; Redelmeier DA; Spiess PE; Sampson HA; Fradet Y; Jewett MA
    J Urol; 2000 Mar; 163(3):752-7. PubMed ID: 10687970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.
    Lotan Y; Roehrborn CG
    J Urol; 2002 Jan; 167(1):75-9. PubMed ID: 11743279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?
    de Bekker-Grob EW; van der Aa MN; Zwarthoff EC; Eijkemans MJ; van Rhijn BW; van der Kwast TH; Steyerberg EW
    BJU Int; 2009 Jul; 104(1):41-7. PubMed ID: 19500328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.
    Lotan Y; Svatek RS; Sagalowsky AI
    Cancer; 2006 Sep; 107(5):982-90. PubMed ID: 16862567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic impact of tumor markers in bladder cancer surveillance.
    Hong YM; Loughlin KR
    Urology; 2008 Jan; 71(1):131-5. PubMed ID: 18242381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
    Yossepowitch O; Herr HW; Donat SM
    J Urol; 2007 Apr; 177(4):1277-82; discussion 1282. PubMed ID: 17382711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
    Kamat AM; Karam JA; Grossman HB; Kader AK; Munsell M; Dinney CP
    BJU Int; 2011 Oct; 108(7):1119-23. PubMed ID: 21426474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis.
    Svatek RS; Sagalowsky AI; Lotan Y
    Urol Oncol; 2006; 24(4):338-43. PubMed ID: 16818188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.
    Donat SM; Bayuga S; Herr HW; Berwick M
    J Urol; 2003 Nov; 170(5):1777-80. PubMed ID: 14532774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of a test to detect metastases for endometrial cancer.
    Havrilesky LJ; Maxwell GL; Chan JK; Myers ER
    Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.
    Boman H; Hedelin H; Holmäng S
    J Urol; 2002 Jan; 167(1):80-3. PubMed ID: 11743280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
    Giannopoulos A; Manousakas T; Gounari A; Constantinides C; Choremi-Papadopoulou H; Dimopoulos C
    J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database.
    Mariappan P; Smith G
    J Urol; 2005 Apr; 173(4):1108-11. PubMed ID: 15758711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer biomarkers and their role in surveillance and screening.
    Van Tilborg AA; Bangma CH; Zwarthoff EC
    Int J Urol; 2009 Jan; 16(1):23-30. PubMed ID: 19120523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.